Close
Almac
Achema middle east

Upsher-Smith launches new prenatal vitamin

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Eli Lilly & IU Join Hands to Expand Clinical Trials Access

A new agreement as per which Eli Lilly and...

IQVIA Agentic AI Platform Builds New Capabilities with AWS

IQVIA, known across the life sciences industry for its...

Industrial Boiler Water Treatment: Best Practices For Modern Plant Operations

Industrial boilers sit at the center of many plant...
- Advertisement -

Upsher-Smith Laboratories has launched B-Nexa, a prescription prenatal vitamin for pregnant women who suffer from nausea and vomiting of pregnancy (NVP).

B-Nexa is designed with B vitamins and ginger to help calm NVP, also known as morning sickness, the most common symptom of pregnancy, the company said. Taken once or twice daily, B-Nexa contains vitamin B6 and ginger to help calm nausea and vomiting during pregnancy. Each antihistamine-free tablet also contains 1.2mg folic acid.

Upsher-Smith medical affairs senior director Wesley Todd said that B-Nexa is a new option in the prenatal nutrition market that has been designed to help calm nausea and vomiting of pregnancy.

Latest stories

Related stories

Eli Lilly & IU Join Hands to Expand Clinical Trials Access

A new agreement as per which Eli Lilly and...

IQVIA Agentic AI Platform Builds New Capabilities with AWS

IQVIA, known across the life sciences industry for its...

Industrial Boiler Water Treatment: Best Practices For Modern Plant Operations

Industrial boilers sit at the center of many plant...

Regeneron Looks to Infusing More Funds into Gene Editing

Regeneron Pharmaceuticals is going ahead and investing more funds...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Translate »